4D Molecular Therapeutics, Inc. (FDMT) vs Geron Corporation (GERN)
4D Molecular Therapeutics, Inc. and Geron Corporation are both Biotechnology companies. 4D Molecular Therapeutics, Inc. and Geron Corporation are of similar size ($815.9M and $807.1M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against 24.4%. Geron Corporation has the higher net margin (−33.1% vs −194.7%) and the higher return on invested capital (−89.9% vs −186.9%). Across the 18 metrics below, Geron Corporation leads on 12 and 4D Molecular Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | FDMT | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.51% | 65.16% |
| Operating margin | (214.24%) | (25.31%) | 0.00% |
| Net margin | (194.74%) | (33.05%) | 0.00% |
| Free cash flow margin | (169.51%) | (56.10%) | 0.00% |
| Return on equity | (43.25%) | (28.28%) | (57.72%) |
| Return on assets | (37.09%) | (12.59%) | (49.22%) |
| Return on invested capital | (186.91%) | (89.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack